Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2859 | 2400 | 29.2 | 64% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
502 | 19766 | FABRY DISEASE//GAUCHER DISEASE//MUCOPOLYSACCHARIDOSES |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
13328 | 780 | CYSTINOSIS//SALLA DISEASE//NEPHROPATHIC CYSTINOSIS |
14272 | 714 | PANTETHEINASE//PANTOTHENATE SYNTHETASE//COENZYME A |
16693 | 576 | PKAN//HALLERVORDEN SPATZ SYNDROME//NBIA |
22274 | 330 | PANTETHINE//ALLITHIAMINE//ALLITHIAMIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CYSTINOSIS | Author keyword | 330 | 86% | 7% | 171 |
2 | PANTOTHENATE KINASE | Author keyword | 67 | 89% | 1% | 31 |
3 | PKAN | Author keyword | 67 | 87% | 1% | 33 |
4 | HALLERVORDEN SPATZ SYNDROME | Author keyword | 64 | 82% | 2% | 37 |
5 | PANTETHEINASE | Author keyword | 53 | 95% | 1% | 18 |
6 | NBIA | Author keyword | 50 | 74% | 2% | 37 |
7 | HALLERVORDEN SPATZ DISEASE | Author keyword | 48 | 77% | 1% | 33 |
8 | SALLA DISEASE | Author keyword | 45 | 83% | 1% | 25 |
9 | PANK2 | Author keyword | 38 | 93% | 1% | 14 |
10 | PLA2G6 | Author keyword | 35 | 76% | 1% | 25 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYSTINOSIS | 330 | 86% | 7% | 171 | Search CYSTINOSIS | Search CYSTINOSIS |
2 | PANTOTHENATE KINASE | 67 | 89% | 1% | 31 | Search PANTOTHENATE+KINASE | Search PANTOTHENATE+KINASE |
3 | PKAN | 67 | 87% | 1% | 33 | Search PKAN | Search PKAN |
4 | HALLERVORDEN SPATZ SYNDROME | 64 | 82% | 2% | 37 | Search HALLERVORDEN+SPATZ+SYNDROME | Search HALLERVORDEN+SPATZ+SYNDROME |
5 | PANTETHEINASE | 53 | 95% | 1% | 18 | Search PANTETHEINASE | Search PANTETHEINASE |
6 | NBIA | 50 | 74% | 2% | 37 | Search NBIA | Search NBIA |
7 | HALLERVORDEN SPATZ DISEASE | 48 | 77% | 1% | 33 | Search HALLERVORDEN+SPATZ+DISEASE | Search HALLERVORDEN+SPATZ+DISEASE |
8 | SALLA DISEASE | 45 | 83% | 1% | 25 | Search SALLA+DISEASE | Search SALLA+DISEASE |
9 | PANK2 | 38 | 93% | 1% | 14 | Search PANK2 | Search PANK2 |
10 | PLA2G6 | 35 | 76% | 1% | 25 | Search PLA2G6 | Search PLA2G6 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEPHROPATHIC CYSTINOSIS | 237 | 75% | 7% | 171 |
2 | CYSTEAMINE THERAPY | 197 | 98% | 2% | 50 |
3 | HALLERVORDEN SPATZ SYNDROME | 108 | 53% | 6% | 142 |
4 | COENZYME A BIOSYNTHESIS | 87 | 78% | 2% | 57 |
5 | KINASE ASSOCIATED NEURODEGENERATION | 65 | 60% | 3% | 72 |
6 | CTNS MUTATIONS | 61 | 88% | 1% | 29 |
7 | CORNEAL CRYSTALS | 57 | 95% | 1% | 19 |
8 | PANTOTHENATE KINASE | 46 | 70% | 2% | 39 |
9 | INFANTILE CYSTINOSIS | 45 | 94% | 1% | 16 |
10 | PANK2 | 42 | 83% | 1% | 24 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cystinosis | 2002 | 205 | 48 | 96% |
Clinical and genetic delineation of neurodegeneration with brain iron accumulation | 2009 | 116 | 50 | 78% |
Coenzyme A: Back in action | 2005 | 158 | 166 | 63% |
Cystinosis: the evolution of a treatable disease | 2013 | 16 | 57 | 91% |
Genetics of Neurodegeneration with Brain Iron Accumulation | 2011 | 47 | 41 | 61% |
Neuroimaging Features of Neurodegeneration with Brain Iron Accumulation | 2012 | 43 | 33 | 55% |
Syndromes of Neurodegeneration with Brain Iron Accumulation (NBIA): an Update on Clinical Presentations, Histological and Genetic Underpinnings, and Treatment Considerations | 2012 | 34 | 79 | 63% |
Nephropathic cystinosis: an international consensus document | 2014 | 4 | 60 | 93% |
Iron metabolism in the CNS: implications for neurodegenerative diseases | 2013 | 41 | 128 | 29% |
Nephropathic cystinosis: late complications of a multisystemic disease | 2008 | 44 | 108 | 96% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT HUMAN BIOCHEM GENET | 12 | 29% | 1.5% | 35 |
2 | LEHRSTUHL MIKROBIELLE GENET | 8 | 60% | 0.4% | 9 |
3 | PIERFRANCO LUISA MARIANI STUDY MITOCHONDRIA | 5 | 60% | 0.3% | 6 |
4 | STRUCT FUNCT NUCL ACID | 4 | 75% | 0.1% | 3 |
5 | ILLING SECT CLIN MOL NEUROGENET | 4 | 38% | 0.3% | 8 |
6 | GENET FUNKT GENOMFOR | 2 | 67% | 0.1% | 2 |
7 | NEUROMUSCULAR NEUROMETAB DISORDERS | 2 | 67% | 0.1% | 2 |
8 | NEMOURS PROGRAMS | 2 | 33% | 0.2% | 4 |
9 | HUMAN GENET BRANCH HUMAN BIOCHEM GENET SECT | 1 | 100% | 0.1% | 2 |
10 | MEMBRANE PUMPS CELLS DISPUMPKIN | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000012848 | PEPTIDE DEFORMYLASE//ENOYL ACP REDUCTASE//PLATENSIMYCIN |
2 | 0.0000009169 | ALPHA SYNUCLEIN//PARKIN//LRRK2 |
3 | 0.0000008284 | FABRY DISEASE//GAUCHER DISEASE//MUCOPOLYSACCHARIDOSES |
4 | 0.0000007589 | MAPLE SYRUP URINE DISEASE//METHYLMALONIC ACIDEMIA//JOURNAL OF INHERITED METABOLIC DISEASE |
5 | 0.0000007069 | THIAMINE DEFICIENCY//THIAMINE//WERNICKES ENCEPHALOPATHY |
6 | 0.0000005791 | CARNITINE//L CARNITINE//PROPIONYL L CARNITINE |
7 | 0.0000005314 | ADENYLATE KINASE//THYMIDYLATE KINASE//CHIM STRUCT MACROMOL |
8 | 0.0000005195 | HEREDITARY SPASTIC PARAPLEGIA//FRIEDREICHS ATAXIA//FRIEDREICH ATAXIA |
9 | 0.0000005125 | SOMATOSTATIN//HYPERPOLARIZED C 13//SOMATOSTATIN RECEPTORS |
10 | 0.0000005052 | TRANSHYDROGENASE//WLDS//NAD KINASE |